C-Met Modulators and Methods of Use
US-2015376133-A1 · Dec 31, 2015 · US
US9278934B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9278934-B2 |
| Application number | US-201214128305-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 29, 2012 |
| Priority date | Jun 29, 2011 |
| Publication date | Mar 8, 2016 |
| Grant date | Mar 8, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a novel method for producing fine particles of aripiprazole anhydride crystals B. The method for producing fine particles of aripiprazole anhydride crystals B comprises the steps of: (1) heating and dissolving crude aripiprazole in a lower alcohol, and subsequently cooling the resulting mixture to precipitate crystals to obtain crystals of aripiprazole lower alcohol solvate; (2) subjecting the crystals of aripiprazole lower alcohol solvate to wet-milling in the form of a slurry containing the lower alcohol; and (3) subjecting the dispersion of the wet-milled crystals to solid-liquid separation to obtain the crystals, and heating the crystals.
Opening claim text (preview).
The invention claimed is: 1. A method for producing fine particles of aripiprazole anhydride crystals B, the method comprising the steps of: (a) heating and dissolving crude aripiprazole in a lower alcohol, and subsequently cooling the resulting mixture to precipitate crystals to obtain crystals of aripiprazole lower alcohol solvate; (b) subjecting the crystals of aripiprazole lower alcohol solvate to wet-milling in the form of a slurry containing the lower alcohol; and (c) subjecting the dispersion of the wet-milled crystals to solid-liquid separation to obtain the crystals, and heating the crystals. 2. The production method according to claim 1 , wherein the volume average particle size of the obtained fine particles of aripiprazole anhydride crystals B is less than 50 μm. 3. The production method according to claim 1 or 2 , wherein the lower alcohol is methanol or ethanol. 4. The production method according to claim 3 , wherein the lower alcohol is ethanol. 5. The production method according to claim 4 , wherein the lower alcohol substantially contains no water. 6. The production method according to claim 5 , wherein the water content in the lower alcohol is less than 10 vol %. 7. The production method according to claim 6 , wherein the volume average particle size of the wet-milled crystals in step (b) is less than 50 μm. 8. The production method according to claim 7 , wherein the volume average particle size of the wet-milled crystals in step (b) is 15 to 20 μm. 9. The production method according to claim 1 or 2 , wherein the heating temperature in step (c) is in the range near the boiling point of the lower alcohol to about 125° C. 10. The production method according to claim 1 or 2 , wherein the lower alcohol is ethanol, and the heating temperature in step (c) is in the range of about 78 to 125° C.
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia · CPC title
attached in position 2 or 4 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.